Sandoz CEO very happy with Slovenian subsidiary
Basel, 2 February - Sandoz, the generics arm of Swiss drug maker Novartis, is set to reassess its operations across the globe. However, its Slovenian subsidiary, Lek Sandoz, does not have to fear for the future, having been described as "one of our jewels" by Sandoz CEO Richard Francis.
The rest of this news item is available to subscribers.
The news item consists of 1.342 characters (without spaces) or 269 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.